This is in line with a prior prospective clinical trial that revealed persistent cancer worries following preventive salpingectomy with delayed oophorectomy or standard salpingo‐oophorectomy in BRCA1/2 carriers.18 The gene discussed is BRCA1; the disease is cancer.